Nonequivalent response to bromodomain-targeting BET inhibitors in oligodendrocyte cell fate decision

Cheng-Ming Chiang1

  • 1Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA; Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA; Department of Pharmacology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

Chemistry & Biology
|July 19, 2014
PubMed